We recently showed that APOE ε4 carriers, irrespective of cognitive status in AD and mild cognitive impairment, had the same proteomic signature in the cerebrospinal fluid (CSF) associated with a pro-inflammatory immune molecular phenotype17. The gene discussed is APOE; the disease is Cognitive impairment.